Craving for heroin: difference between methadone maintenance therapy patients with and without ADHD
Fissura por heroína: diferença entre pacientes em terapia de manutenção com metadona com e sem TDAH
Maurizio Coppola; Giuseppe Sacchetto; Raffaella Mondola
Abstract
Keywords
Resumo
Palavras-chave
References
Volkow ND, Swanson JM. Adult attention deficit-hyperactivity disorder. N Engl J Med. 2013;369:1935-44.
Wender PH. Attention deficit-hyperactivity disorder in adults. Psychiatr Clin North Am. 1988;21:761-74.
Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow up studies. Psychol Med. 2006;36:159-65.
Wilens TE, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict. 1998;7:156-63.
Gholamalinezhad F, Abdolmanafi A, Rostami R, Farhoodi F. Comparison of craving in substance use patients with the history of ADHD and substance use without ADHD history. Procedia Soc Behav Sci. 2010;5.
Frodl T. Comorbidity of ADHD and substance use disorder (SUD): a neuroimaging perspective. J Atten Disord. 2010;14:109-20.
Volkow ND, Wang GJ, Kollins SH, Wigal TL, Newcorn JH, Telang F. Evaluating dopamine reward pathway in ADHD. JAMA. 2009;302:1084-91.
Zulauf CA, Sprich SE, Safren SA, Wilens TE. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Curr Psychiatry Rep. 2014;16.
Oshri A, Kogan SM, Kwon JA, Wickrama KAS, Vanderbroek L, Palmer AA. Impulsivity as a mechanism linking child abuse and neglect with substance use in adolescence and adulthood. Dev Psychopathol. 2017;30:417-35.
Gipson CD, Beckmann JS, Adams ZW, Marusich JA, Nesland TO, Yates JR. A translational behavioral model of mood-based impulsivity: Implications for substance abuse. Drug Alcohol Depend. 2012;122:93-9.
First MB, Williams JWB, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5® Disorders--Clinician Version (SCID-5-CV). 2016.
Wesson DR, Ling W. The Clinical Opiate Withdrawal Scale (COWS). J Psychoactive Drugs. 2003;35:253-9.
Ramos-Quiroga JA, Nasillo V, Richarte V, Corrales M, Palma F, Ibáñez P. Criteria and concurrent validity of DIVA 2.0: a semi-structured diagnostic interview for adult ADHD. J Atten Disord. 2016.
First MB, Williams JWB, Karg RS, Spitzer RL. Structured Clinical Interview for DSM-5® Personality Disorders (SCID-5-PD). 2016.
Hassani-Abharian P, Ganjgahi H, Tabatabaei-Jafari H, Oghabian MA, Mokri A, Ekhtiari H. Exploring neural correlates of different dimensions in drug craving self-reports among heroin dependents. Basic Clin Neurosci. 2015;6:271-84.
Falcato L, Beck T, Reimer J, Verthein U. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial. J Clin Psychopharmacol. 2015;35:150-7.
Zhao M, Fan C, Du J, Jiang H, Chen H, Sun H. Cue-induced craving and physiological reactions in recently and long-abstinent heroin-dependent patients. Addict Behav. 2012;37:393-8.
van Emmerik-van Oortmerssena K, van de Glindc G, van den Brinkb W, Smitc F, Crunelle CL, Swetsa M. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122:11-9.
Stein MT. ADHD: The diagnostic process from different perspectives. J Dev Behav Pediatr. 2004;25:S54-8.
Regnart J, Truter I, Meyer A. Critical exploration of co-occurring attention-deficit/hyperactivity disorder, mood disorder and substance use disorder. Expert Rev Pharmacoecon Outcomes Res. 2017;17:275-82.
Volkowa ND, Wangc GJ, Fowlerc JS, Tomasib D, Telangb F. Addiction: beyond dopamine reward circuitry. PANS. 2011;108:15037-42.
Scott JG, Giørtz Pedersen M, Erskine HE, Bikic A, Demontis D, McGrath JJ. Mortality in individuals with disruptive behavior disorders diagnosed by specialist services - A nationwide cohort study. Psychiatry Res. 2017;251:255-60.